XNASZJYL
Market cap140mUSD
Dec 23, Last price
0.90USD
1D
4.65%
1Q
-67.51%
IPO
126.87%
Name
Jin Medical International Ltd
Chart & Performance
Profile
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|
2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | |
Income | ||||||
Revenues | 19,821 3.29% | 19,191 -7.58% | ||||
Cost of revenue | 16,954 | 17,060 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 2,867 | 2,131 | ||||
NOPBT Margin | 14.47% | 11.10% | ||||
Operating Taxes | 344 | 36 | ||||
Tax Rate | 11.99% | 1.69% | ||||
NOPAT | 2,524 | 2,094 | ||||
Net income | 2,878 6.34% | 2,707 2.84% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 8,000 | |||||
BB yield | -94.22% | |||||
Debt | ||||||
Debt current | 4,113 | |||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | (12,585) | (6,204) | ||||
Cash flow | ||||||
Cash from operating activities | 3,106 | 1,581 | ||||
CAPEX | (114) | (40) | ||||
Cash from investing activities | (7,730) | (121) | ||||
Cash from financing activities | 6,911 | 122 | ||||
FCF | (1,016) | 2,270 | ||||
Balance | ||||||
Cash | 16,698 | 7,069 | ||||
Long term investments | (865) | |||||
Excess cash | 15,707 | 5,245 | ||||
Stockholders' equity | 17,542 | 15,156 | ||||
Invested Capital | 12,385 | 9,743 | ||||
ROIC | 22.81% | 21.13% | ||||
ROCE | 10.21% | 14.22% | ||||
EV | ||||||
Common stock shares outstanding | 7,257 | 8,000 | ||||
Price | 1.17 | |||||
Market cap | 8,491 | |||||
EV | (4,095) | |||||
EBITDA | 3,093 | 2,493 | ||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |